Literature DB >> 8283880

Surgical treatment of active infective endocarditis with paravalvular involvement.

G Watanabe1, A Haverich, R Speier, C Dresler, H G Borst.   

Abstract

Aortic root infection remains a challenging problem in the surgical treatment of both native and prosthetic valve endocarditis. Between 1980 and 1991, 73 patients with active aortic valve endocarditis and paravalvular infection underwent operation. Indications for operation included congestive heart failure and uncontrolled sepsis. Aortic root abscesses were located in the noncoronary anulus or in the aorticomitral junction in 45% of cases, followed by the subannular interventricular septum in 23%. Two patients had an aorticoatrial fistula, seven an interventricular septal defect. Total or partial left ventricular-aortic dehiscence was observed in 27 patients. All patients underwent aortic valve replacement, nine with simultaneous mitral valve operations. Two of the latter required patch reconstruction of the destroyed aorticomitral septum with double valve replacement. Reconstruction of the aortic base was possible in 16 patients, whereas in 12 total replacement of the aortic root was necessary. In one patient, supracoronary aortic valve replacement was used. Recently, topical application of antibiotics in fibrin sealant was used in 25 patients. The operative mortality rate was 21% and correlated to preoperative uncontrolled sepsis and the presence of extensive root destruction. Operation for active endocarditis of the aortic root requires radical, individualized techniques and results in an acceptable operative and long-term risk. The use of an antibiotic fibrin compound appears to be a useful prophylactic tool to prevent postoperative residual endocarditis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8283880

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  [A case of active infective endocarditis in the remission phase of virus-associated hemophagocytic syndrome].

Authors:  I Arioka; H Maeta; A Takazawa; T Ukawa; K Mizoguchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-06

2.  Aortic-left ventricular discontinuity of noninfectious origin.

Authors:  L Penninga; J Partridge; M Amrani
Journal:  Neth Heart J       Date:  2003-08       Impact factor: 2.380

3.  Long term results of mechanical prostheses for treatment of active infective endocarditis.

Authors:  J M Guerra; M P Tornos; G Permanyer-Miralda; B Almirante; M Murtra; J Soler-Soler
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

4.  [Long-term results after surgery for acute aortic endocarditis].

Authors:  P R Vogt; H P Brunner-Larocca
Journal:  Z Kardiol       Date:  2001-12

5.  Subverting bacterial resistance using high dose, low solubility antibiotics in fibrin.

Authors:  C J Woolverton; K Huebert; B Burkhart; M MacPhee
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

6.  [Surgical therapy of acute endocarditis of the aortic valve with paravalvular abscess. 7 years experiences].

Authors:  Calin Vicol; Gert Barth
Journal:  Wien Med Wochenschr       Date:  2003

7.  Pseudoaneurysm from the mitral-aortic intervalvular fibrosa following endocarditis.

Authors:  Yukifusa Yokoyama; Shuji Tamaki; Noriyuki Kato; Jun Yokote; Masato Mutsuga
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-08

8.  Evaluation and management of aortic valve and root disease.

Authors:  John B de Graft-Johnson; Thomas G Gleason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

9.  Reoperative Aortic Root Replacement in Patients with Previous Aortic Root or Aortic Valve Procedures.

Authors:  Byung Kwon Chong; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee; Joon Bum Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-08-05

10.  Surgical treatment and long-term outcome of aortic valve endocarditis with periannular abscess.

Authors:  S I Croon; A Angkasuwan; A H van Straten; A Khamooshian; T W Elenbaas; M A Soliman-Hamad
Journal:  Neth Heart J       Date:  2020-06       Impact factor: 2.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.